Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis

Disease Markers

Volumn 2016, Issue , 2016, Pages

  Sun, Jingxu ^a   Chen, Xiaowan ^a   Gao, Peng ^a   Song, Yongxi ^a   Huang, Xuanzhang ^a   Yang, Yuchong ^a   Zhao, Junhua ^a   Ma, Bin ^a   Gao, Xinghua ^a   Wang, Zhenning ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; GASTRECTOMY; HUMAN; METASTASIS RESECTION; NEUTROPHIL LYMPHOCYTE RATIO; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PUBLISHING; REVIEW; STOMACH CANCER; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; IMMUNOLOGY; LYMPHOCYTE COUNT; META ANALYSIS; NEUTROPHIL; PREDICTIVE VALUE; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

HUMANS; LYMPHOCYTE COUNT; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84958078592     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2016/7862469     Document Type: Review

References (50)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward, "Cancer statistics, 2010," CA - Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277-300, 2010.
2. W. Wang, Y.-F. Li, X.-W. Sun et al., "Prognosis of 980 patients with gastric cancer after surgical resection," Chinese Journal of Cancer, vol. 29, no. 11, pp. 923-930, 2010.
3. Y. Fujiwara, S. Takiguchi, K. Nakajima et al., "Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination," Annals of Surgical Oncology, vol. 18, no. 13, pp. 3726-3731, 2011.
4. C. Kunisaki, M. Takahashi, H. Makino et al., "Phase II study of biweekly docetaxel and S-1 combination chemotherapy as firstline treatment for advanced gastric cancer," Cancer Chemotherapy and Pharmacology, vol. 67, no. 6, pp. 1363-1368, 2011.
5. H. M. Yoon, K. W. Ryu, B. H. Nam et al., "Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer?" Journal of the American College of Surgeons, vol. 214, no. 1, pp. 88-96, 2012.
6. B. B. Aggarwal, R. V. Vijayalekshmi, and B. Sung, "Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe," Clinical Cancer Research,vol. 15, no. 2, pp. 425-430, 2009.
7. S. I. Grivennikov, F. R. Greten, and M. Karin, "Immunity, inflammation, and cancer," Cell, vol. 140, no. 6, pp. 883-899, 2010.
8. T. Nozoe, T. Iguchi, E. Adachi, A. Matsukuma, and T. Ezaki, "Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer," Surgery Today, vol. 41, no. 4, pp. 510-513, 2011.
9. H. Mönig, D. Marquardt, T. Arendt, and S. Kloehn, "Limited value of elevated erythrocyte sedimentation rate as an indicator of malignancy," Family Practice, vol. 19, no. 5, pp. 436-438, 2002.
10. M. Pichler, G. C. Hutterer, C. Stoeckigt et al., "Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients," British Journal of Cancer, vol. 108, no. 4, pp. 901-907, 2013.
11. B. S. Oh, J. W. Jang, J. H. Kwon et al., "Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma," BMC Cancer, vol. 13, article 78, 2013.
12. W. Chua, K. A. Charles, V. E. Baracos, and S. J. Clarke, "Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer," British Journal of Cancer, vol. 104, no. 8, pp. 1288-1295, 2011.
13. N. Jiang, J.-Y. Deng, Y. Liu, B. Ke, H.-G. Liu, and H. Liang, "The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer," Biomarkers, vol. 19, no. 6, pp. 444-451, 2014.
14. D.-S. Wang, C. Ren, M.-Z. Qiu et al., "Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer," Tumor Biology, vol. 33, no. 3, pp. 749-756, 2012.
15. A. Liberati, D. G. Altman, J. Tetzlaff et al., "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration," PLoS Medicine, vol. 6, no. 7, Article ID e1000100, 2009.
16. G. A. Wells, B. Shea, D. O'Connell et al., "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses," http://www.ohri.ca/programs/clinical-epidedemiology/oxford.asp.
17. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, "Practical methods for incorporating summary time-to-event data into meta-analysis," Trials, vol. 8, article16, 2007.
18. Y. Mohri, K. Tanaka, M. Ohi et al., "Identification of prognostic factors and surgical indications for metastatic gastric cancer," BMC Cancer, vol. 14, no. 1, article 409, 2014.
19. L. Graziosi, E. Marino, V. De Angelis, A. Rebonato, E. Cavazzoni, and A. Donini, "Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer," The American Journal of Surgery, vol. 209, no. 2, pp. 333-337, 2015.
20. I. R. Cho, J. C. Park, C. H. Park et al., "Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer," Gastric Cancer, vol. 17, no. 4, pp. 703-710, 2014.
21. P. Aurello, S. M. Tierno, G. Berardi et al., "Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer," Annals of Surgical Oncology, vol. 21, no. 6, pp. 1998-2004, 2014.
22. L. M. A. El Aziz, "Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4," Medical Oncology, vol. 31, article 311, 2014.
23. S. Lee, S. Y. Oh, S. H. Kim et al., "Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy," BMC Cancer, vol. 13, article 350, 2013.
24. D. Y. Lee, S. W. Hong, Y. G. Chang, W. Y. Lee, and B. Lee, "Clinical significance of preoperative inflammatory parameters in gastric cancer patients," Journal of Gastric Cancer, vol. 13, no. 2, pp. 111-116, 2013.
25. H. Jin, G. Zhang, X. Liu et al., "Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy," World Journal of Surgical Oncology, vol. 11, article 112, 2013.
26. A. Dirican, N. Ekinci, A. Avci et al., "The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer," Cancer Biomarkers, vol. 13, no. 1, pp. 11-20, 2013.
27. C. Kunisaki, M. Takahashi, H. A. Ono et al., "Inflammationbased prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and S-1 combination chemotherapy," Oncology, vol. 83, no. 4, pp. 183- 191, 2012.
28. Y. H. Kim and W. J. Choi, "The effectiveness of postoperative neutrophils to lymphocytes ratio in predicting long-term recurrence after stomach cancer surgery," Journal of the Korean Surgical Society, vol. 83, no. 6, pp. 352-359, 2012.
29. J.-H. Jeong, S. M. Lim, J. Y. Yun et al., "Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer," Oncology, vol. 83, no. 5, pp. 292-299, 2012.
30. M. R. Jung, Y. K. Park, O. Jeong et al., "Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer,"Journal of Surgical Oncology, vol. 104, no. 5, pp. 504-510, 2011.
31. H. Ubukata, G. Motohashi, T. Tabuchi, H. Nagata, S. Konishi, and T. Tabuchi, "Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients," Journal of Surgical Oncology, vol. 102, no. 7, pp. 742-747, 2010.
32. H. Shimada, N. Takiguchi, O. Kainuma et al., "High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer," Gastric Cancer, vol. 13, no. 3, pp. 170-176, 2010.
33. Y. Mohri, K. Tanaka, M. Ohi, T. Yokoe, C. Miki, and M. Kusunoki, "Prognostic significance of host- and tumor-related factors in patients with gastric cancer," World Journal of Surgery, vol. 34, no. 2, pp. 285-290, 2010.
34. T. Yamanaka, S. Matsumoto, S. Teramukai, R. Ishiwata, Y. Nagai, and M. Fukushima, "The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer," Oncology, vol. 73, no. 3-4, pp. 215-220, 2007.
35. H. Y. Shau and S. H. Golub, "Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils," Journal of Immunology, vol. 143, no. 3, pp. 1066- 1072, 1989.
36. M. R. Hussein and R. A. Ahmed, "Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pretumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin," Cancer Biology & Therapy, vol. 4, no. 8, pp. 819-821, 2005.
37. Y. B. Cihan, A. Ozturk, and H. Mutlu, "Relationship between prognosis and neutrophil: lymphocyte and platelet: Lymphocyte ratios in patients with malignant pleural mesotheliomas," Asian Pacific Journal of Cancer Prevention, vol. 15, no. 5, pp. 2061-2067, 2014.
38. Y. Wei, Y.-Z. Jiang, and W.-H. Qian, "Prognostic role of NLR in urinary cancers: a meta-analysis," PLoS ONE, vol. 9, no. 3, Article ID e92079, 2014.
39. M.-X. Li, X.-M. Liu, X.-F. Zhang et al., "Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis," International Journal of Cancer, vol. 134, no. 10, pp. 2403-2413, 2014.
40. G. Malietzis, M. Giacometti, R. H. Kennedy, T. Athanasiou, O. Aziz, and J. T. Jenkins, "The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis," Annals of Surgical Oncology, vol. 21, no. 12, pp. 3938-3946, 2014.
41. Y. Matsumoto, H. Marusawa, K. Kinoshita et al., "Helicobacter pylori infection triggers aberrant expression of activationinduced cytidine deaminase in gastric epithelium," Nature Medicine, vol. 13, no. 4, pp. 470-476, 2007.
42. Y. H. Kusumanto, W. A. Dam, G. A. P. Hospers, C. Meijer, and N. H. Mulder, "Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor," Angiogenesis, vol. 6, no. 4, pp. 283-287, 2003.
43. E. Jablonska, W. Puzewska, Z. Grabowska, J. Jablonski, and L. Talarek, "VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer," Cytokine, vol. 30, no. 3, pp. 93-99, 2005.
44. V. C. Ardi, T. A. Kupriyanova, E. I. Deryugina, and J. P. Quigley, "Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 51, pp. 20262-20267, 2007.
45. M. J. Smyth, G. P. Dunn, and R. D. Schreiber, "Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity," Advances in Immunology, vol. 90, pp. 1-50, 2006.
46. L. Martinet, I. Garrido, T. Filleron et al., "Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer," Cancer Research, vol. 71, no. 17, pp. 5678-5687, 2011.
47. H. T. Petrie, L. W. Klassen, and H. D. Kay, "Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes," The Journal of Immunology, vol. 134, no. 1, pp. 230-234, 1985.
48. P. R. Rohatgi, J. C. Yao, K. Hess et al., "Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival," Cancer, vol. 107, no. 11, pp. 2576-2580, 2006.
49. B. V. Hogan, M. B. Peter, H. G. Shenoy, K. Horgan, and T. A. Hughes, "Surgery induced immunosuppression," Surgeon, vol. 9, no. 1, pp. 38-43, 2011.
50. X. Zhang, W. Zhang, and L.-J. Feng, "Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis," PLoS ONE, vol. 9, no. 11, Article ID e111906, 2014.